Mutations let JC polyomavirus evade antibodies, offering clues for vaccines and treatments

Researchers have identified how the JC polyomavirus mutates to evade human antibodies, a discovery that could lead to new vaccines and treatments for associated brain diseases. The study, published in PNAS, represents a decade of international collaboration.
Why it matters
Understanding viral evasion mechanisms is essential for developing effective medical interventions for immunocompromised patients.
edited by Stephanie Baum , reviewed by Andrew Zinin
The article is a scientific report based on peer-reviewed research findings.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in